Results 231 to 240 of about 145,853 (310)

Prurigo Pigmentosa Following Bariatric Surgery: A Comprehensive Clinicopathological Review

open access: yesDermatology Research and Practice, Volume 2026, Issue 1, 2026.
Prurigo pigmentosa (PP) is a rare inflammatory dermatosis first described in 1971 by Nagashima, classically predominantly affecting young women, particularly those of East Asian descent. Clinically, PP presents with pruritic, erythematous papules, which eventually form a reticulated pattern and resolve into post‐inflammatory hyperpigmentation.
Khalid Nabil Nagshabandi   +6 more
wiley   +1 more source

From Pathophysiology to Treatment: Contemporary Approaches to CFRD in the Pediatric and Adolescent Population

open access: yesPediatric Diabetes, Volume 2026, Issue 1, 2026.
Cystic fibrosis‐related diabetes (CFRD) is the most prevalent nonrespiratory complication of cystic fibrosis (CF), with its prominence growing as survival rates improve due to advances in CFTR modulator therapies. Its prevalence increases with age, affecting nearly 50% of patients with CF (PwCF) over 30 years old.
Dogus Vuralli, Andrea Scaramuzza
wiley   +1 more source

High-Fructose Corn Syrup on Inflammation and Cancer. [PDF]

open access: yesWorld J Oncol
Aoyagi T   +4 more
europepmc   +1 more source

Risks for human health related to the presence of plant lectins in food

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The European Commission asked the European Food Safety Authority (EFSA) to assess the risk related to the presence of plant lectins in food. Based on the available evidence, the CONTAM Panel considered only phytohaemagglutinin (PHA), a legume lectin from beans (Phaseolus sp.), for the risk characterisation.
EFSA Panel on Contaminants in the Food Chain (CONTAM)   +30 more
wiley   +1 more source

Scientific Opinion on the tolerable upper intake level for supplemental docosahexaenoic acid

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract Following a request from the European Commission, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion on the revision of the safe level of intake for supplemental docosahexaenoic acid (DHA).
EFSA Panel on Nutrition   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy